141 related articles for article (PubMed ID: 32502269)
1. Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma.
Iyer A; Hennessey D; O'Keefe S; Patterson J; Wang W; Wong GK; Gniadecki R
Blood Adv; 2020 Jun; 4(11):2489-2500. PubMed ID: 32502269
[TBL] [Abstract][Full Text] [Related]
2. Independent evolution of cutaneous lymphoma subclones in different microenvironments of the skin.
Iyer A; Hennessey D; O'Keefe S; Patterson J; Wang W; Wong GK; Gniadecki R
Sci Rep; 2020 Sep; 10(1):15483. PubMed ID: 32968137
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell Heterogeneity of Cutaneous T-Cell Lymphomas Revealed Using RNA-Seq Technologies.
Rassek K; Iżykowska K
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751918
[TBL] [Abstract][Full Text] [Related]
4. Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy.
García-Díaz N; Piris MÁ; Ortiz-Romero PL; Vaqué JP
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923722
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma.
Jones CL; Degasperi A; Grandi V; Amarante TD; ; Mitchell TJ; Nik-Zainal S; Whittaker SJ
Sci Rep; 2021 Feb; 11(1):3962. PubMed ID: 33597573
[TBL] [Abstract][Full Text] [Related]
6. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
[TBL] [Abstract][Full Text] [Related]
7. MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides.
Chang YT; Prompsy P; Kimeswenger S; Tsai YC; Ignatova D; Pavlova O; Iselin C; French LE; Levesque MP; Kuonen F; Bobrowicz M; Brunner PM; Pascolo S; Hoetzenecker W; Guenova E
Nat Commun; 2024 Jan; 15(1):752. PubMed ID: 38272918
[TBL] [Abstract][Full Text] [Related]
8. Immunosequencing applications in cutaneous T-cell lymphoma.
Mandel J; Gleason L; Joffe D; Bhatti S; Nikbakht N
Front Immunol; 2023; 14():1300061. PubMed ID: 38213330
[TBL] [Abstract][Full Text] [Related]
9. Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.
Jiang TT; Cao S; Kruglov O; Virmani A; Geskin LJ; Falo LD; Akilov OE
J Invest Dermatol; 2024 May; 144(5):1088-1098. PubMed ID: 38036289
[TBL] [Abstract][Full Text] [Related]
10. What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
[TBL] [Abstract][Full Text] [Related]
11. Extranodal lymphoma: pathogenesis, diagnosis and treatment.
Yang H; Xun Y; Ke C; Tateishi K; You H
Mol Biomed; 2023 Sep; 4(1):29. PubMed ID: 37718386
[TBL] [Abstract][Full Text] [Related]
12. Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma.
Lefebvre MN; Borcherding N; Reis RJ; Mou E; Liu V; Jabbari A
Front Immunol; 2023; 14():1228563. PubMed ID: 37654486
[TBL] [Abstract][Full Text] [Related]
13. Sézary syndrome originates from heavily mutated hematopoietic progenitors.
Harro CM; Sprenger KB; Chaurio RA; Powers JJ; Innamarato P; Anadon CM; Zhang Y; Biswas S; Mandal G; Mine JA; Cortina C; Nagy MZ; Martin AL; Handley KF; Borjas GJ; Chen PL; Pinilla-Ibarz J; Sokol L; Yu X; Conejo-Garcia JR
Blood Adv; 2023 Sep; 7(18):5586-5602. PubMed ID: 37531660
[TBL] [Abstract][Full Text] [Related]
14. Is Cutaneous T-Cell Lymphoma Caused by Ultraviolet Radiation? A Comparison of UV Mutational Signatures in Malignant Melanoma and Mycosis Fungoides.
Gniadecki R; O'Keefe S; Hennessey D; Iyer A
Cells; 2023 Jun; 12(12):. PubMed ID: 37371087
[TBL] [Abstract][Full Text] [Related]
15. Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma.
Kalliara E; Belfrage E; Gullberg U; Drott K; Ek S
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190290
[TBL] [Abstract][Full Text] [Related]
16. New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications.
Luna DE; Shinohara MM
Curr Hematol Malig Rep; 2023 Jun; 18(3):83-88. PubMed ID: 37017872
[TBL] [Abstract][Full Text] [Related]
17. Advances in the understanding and treatment of Cutaneous T-cell Lymphoma.
Bakr FS; Whittaker SJ
Front Oncol; 2022; 12():1043254. PubMed ID: 36505788
[TBL] [Abstract][Full Text] [Related]
18. Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma.
Xue X; Wang Z; Mi Z; Liu T; Wang C; Shi P; Sun L; Yang Y; Li W; Wang Z; Liu H; Zhang F
Cell Death Dis; 2022 Nov; 13(11):970. PubMed ID: 36400759
[TBL] [Abstract][Full Text] [Related]
19. Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas.
Gallardo F; Pujol RM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291756
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
